Update to CDC’s U.S. Selected Practice Recommendations for Contraceptive Use, 2016

["Centers for Disease Control and Prevention" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Update to CDC’s U.S. Selected Practice Recommendations for Contraceptive Use, 2016

Update to CDC’s U.S. Selected Practice Recommendations for Contraceptive Use, 2016

New Recommendation for Self-administration of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC)

CDC has updated the U.S. Selected Practice Recommendations for Contraceptive Use, 2016 (US SPR) with a new recommendation on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC). CDC’s new recommendation states that self-administered DMPA-SC should be made available as an additional approach to deliver injectable contraception.

Read full report

Selection of Multiple Conditions -- Updated US MEC and US SPR Phone App

CDC has added a new feature to the app for U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) and U.S. Selected Practice Recommendations for Contraceptive Use (US SPR). Providers can now select up to 3 medical conditions or characteristics at once to view recommendations when counseling patients. The updated app is available for iOS and Android operating systems. And if you haven’t used the app before, a new “How To” video has been added to introduce the basic features and learn how to the use new ones.

To learn more about the US MEC and US SPR and to access CDC’s free contraceptive tools, including ordering tools, obtaining CE credits, and downloading speaker slides, tools, resources, and ebook, visit us at CDC Contraceptive Guidance for Health Care Providers.

Follow Us on Twitter @CDC_DRH.